国泰海迪址芬 研究所 X 2025年前多年生生产 8月18、19、25、26日全天 9:00-17:40- 8月25日 (周 周期篇 刘 有色立版 联席首席分析 石油化工 煤炭开展 The Brun 女 公用事业 #分析 澳 Ein 学朋子 海 本 8 期货首席 画區館前 时间安排: 8月18、19、25、26日全天 9:00-17:40 | 8月25日周- | 周期篇 | | --- | --- | | 9:00-9:45 | 非金属类建材研究 | | 9:45-10:30 | 有色金属研究 | | 10:30-11:15 | 公用事业研究 | | 11:15-12:00 | 钢铁研究 | | 13:00-13:45 | 建筑工程研究 | | 13:45-14:30 | 基础化工研究 | | 14:30-15:15 | 交通运输研究 | | 15:15-16:00 | 煤炭开采研究 | | 16:00-16:45 | 石油化工研究 | | 16:45-17:30 | 房地产研究 | *表格更新于2025年8月7日 上海-黄浦区中山南路888号 . . . . . . 本订阅号所载内容仅面向国泰海通证券研究服 ...

Core Viewpoint - The company plans to utilize part of its temporarily idle raised funds for cash management to improve fund efficiency and increase returns for the company and its shareholders [6][9][10]. Summary by Sections Fundraising Overview - The company raised a total of RMB 75,880.00 million from its initial public offering (IPO) in August 2020, with a net amount of RMB 68,955.19 million after deducting issuance costs [1]. - In November 2023, the company raised RMB 18,830.26 million through a targeted issuance of shares, resulting in a net amount of RMB 18,342.53 million after expenses [2]. Investment Projects - The company disclosed that the funds from the IPO were allocated to a high-precision small power testing power supply and fuel cell, power semiconductor testing equipment production base construction project, with a planned use of RMB 27,646.23 million [3]. - The company has excess funds of RMB 41,308.96 million from the IPO, with plans to allocate the surplus to various projects, including a semiconductor testing and intelligent manufacturing equipment industrial park project [3][4]. Cash Management of Idle Funds - The company intends to use up to RMB 23,000 million of temporarily idle raised funds for cash management, with RMB 20,000 million from the IPO and RMB 3,000 million from the 2023 issuance [7][10]. - The cash management will involve investing in low-risk, high-liquidity financial products, ensuring that the funds are not used for non-raising purposes [7][8]. Board Approval and Compliance - The board of directors approved the cash management plan on August 22, 2025, ensuring that it does not affect the progress of investment projects or the safety of the raised funds [10]. - The company has complied with relevant regulations and internal policies regarding the management and use of raised funds, ensuring that the cash management does not alter the intended use of the funds [11].

Core Viewpoint - The company has completed the investment project of the "Semiconductor Testing and Intelligent Manufacturing Equipment Industrial Park" and plans to permanently supplement its working capital with the remaining raised funds, following the completion of the project and the approval of the board and shareholders [6][9][10]. Fundraising Overview - The company raised a total of RMB 758.8 million from its initial public offering, with a net amount of RMB 689.55 million after deducting issuance costs [1]. - The company established a special account for the management and use of the raised funds, ensuring compliance with regulatory requirements [2]. Investment Project Details - The company committed to invest RMB 276.46 million in the "High-Precision Small Power Testing Power Supply and Fuel Cell, Power Semiconductor Testing Equipment Production Base Construction Project" [2]. - The actual net amount raised was RMB 689.55 million, resulting in an excess of RMB 413.09 million after the planned investment [3]. Use of Excess Funds - The company decided to use RMB 120 million of the excess funds to permanently supplement working capital, which constitutes approximately 29.05% of the total excess funds [3][4]. - The remaining excess funds will be allocated to the "Semiconductor Testing and Intelligent Manufacturing Equipment Industrial Park Project," with a total investment of RMB 450 million, of which RMB 300 million will come from excess funds [4][5]. Project Completion and Surplus Funds - As of July 31, 2025, the project has completed its main construction and acceptance work, leading to the decision to conclude the project [6]. - The expected surplus funds amount to RMB 168.27 million, which includes interest and investment income, and will be used to permanently supplement working capital [8][9]. Impact on Company Operations - The decision to conclude the project and use surplus funds for working capital is aligned with the company's operational needs and long-term development strategy, enhancing cash flow and resource allocation [9][10]. - The company will maintain the special account for raised funds until all pending payments are settled, ensuring compliance with regulatory requirements [9]. Approval Process - The board of directors approved the proposal to conclude the investment project and use surplus funds on August 22, 2025, which will also require shareholder approval [10]. - The sponsor institution has confirmed that the decision complies with relevant regulations and is in the best interest of all shareholders [10][11].

Core Viewpoint - The article emphasizes the commitment of Guotai Haitong to social responsibility and rural revitalization through various initiatives and partnerships, showcasing its role as a leading financial enterprise in promoting sustainable development and community welfare [1][12][20]. Group 1: Initiatives and Achievements - Since 2016, Guotai Haitong has integrated political, economic, and social responsibilities, actively responding to national rural revitalization strategies, and has established a "five-in-one" assistance model [1]. - The company has completed a merger and reorganization, increasing the number of supported counties to 10, and held a significant public welfare event focused on rural revitalization [1][20]. - Guotai Haitong has built a comprehensive educational support system, having established six Hope Schools and engaged in various educational initiatives [3][7]. Group 2: Community Engagement and Support - The company has implemented projects like "Love Reading" and "Love Health" in Xinjiang, promoting cultural development and community cohesion [3]. - Employees of Guotai Haitong have taken active roles in rural areas, developing innovative sales models for agricultural products and enhancing local economies [4][5]. - The establishment of the "Rural Revitalization Special Fund" with an initial scale of 10 million yuan aims to empower local industries and support sustainable development [24]. Group 3: Collaborative Efforts - Guotai Haitong collaborates with various partners, including government and educational institutions, to enhance rural development and social welfare projects [12][15]. - The company has initiated the "Love Lunch" project and other health insurance initiatives in partnership with different organizations to support local communities [15][16]. - The "818" event has been transformed into a social cultural festival, reflecting the company's commitment to social responsibility and community engagement [26].

Core Viewpoint - The article discusses the results of the New Fortune Best Analyst Awards, highlighting the top research institutions and their rankings across various sectors, emphasizing the importance of enhancing the quality of research in the Chinese securities industry [31]. Group 1: Rankings of Research Institutions - The top research institutions in the overall category are: 1. GF Securities 2. Industrial Securities 3. Changjiang Securities 4. Shenwan Hongyuan Securities 5. Guosheng Securities [18]. - In the best industry research team category, the rankings are: 1. Changjiang Securities 2. GF Securities 3. Guotai Junan Securities 4. Industrial Securities 5. Shenwan Hongyuan Securities [20]. Group 2: Sector-Specific Rankings - In the financial engineering sector, the top institutions are: 1. Changjiang Securities 2. Industrial Securities 3. Guosheng Securities 4. GF Securities 5. Shenwan Hongyuan Securities [4]. - For the non-banking financial sector, the leading institutions are: 1. Guotai Junan Securities 2. GF Securities 3. Dongwu Securities 4. Changjiang Securities 5. Industrial Securities [5]. Group 3: Additional Sector Rankings - In the food and beverage sector, the top institutions are: 1. Changjiang Securities 2. GF Securities 3. Guotai Junan Securities 4. Huachuang Securities 5. Huaxi Securities [6]. - For the healthcare sector, the leading institutions are: 1. Industrial Securities 2. Tianfeng Securities 3. Guosheng Securities [6]. Group 4: Overall Impact and Purpose - The New Fortune Best Analyst Awards aim to promote the improvement of the research level in the Chinese securities industry, advocating for a professional standard that combines ethics and talent, contributing positively to the development of a modern capital market in China [31].

国泰海通证券股份有限公司 关于中巨芯科技股份有限公司 首次公开发行部分战略配售限售股上市流通的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐机构"）作为 中巨芯科技股份有限公司（以下简称"中巨芯"或"公司"）首次公开发行股票 并在科创板上市及持续督导的保荐机构，根据《证券发行上市保荐业务管理办法》 《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律 监管指引第 1 号——规范运作》等法律法规的相关规定，对中巨芯首次公开发行 部分战略配售限售股上市流通事项进行了核查，核查情况及核查意见如下： 一、本次上市流通的限售股类型 根据中国证券监督管理委员会于 2023 年 6 月 13 日出具的《关于同意中巨芯 （证监许可〔2023〕1278 号）， 科技股份有限公司首次公开发行股票注册的批复》 同意公司首次公开发行股票的注册申请，并经上海证券交易所同意，公司首次向 社会公开发行人民币普通股（A 股）股票 369,319,000 股，并于 2023 年 9 月 8 日 在上海证券交易所科创板上市，发行后公司总股本为 1,477,276,000 股，其中有 限售条件流通股 1,215 ...

国泰海通证券股份有限公司 关于上海奥浦迈生物科技股份有限公司 调整2025年度部分日常关联交易预计额度的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐机构"）作为 上海奥浦迈生物科技股份有限公司（以下简称"奥浦迈"或"公司"）首次公开 发行股票并在科创板上市持续督导的保荐机构，根据《证券发行上市保荐业务 管理办法》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上 市公司自律监管指引第 1 号——规范运作》等相关法律、法规和规范性文件的 规定，对奥浦迈调整 2025 年度部分日常关联交易预计额度的的事项进行了专项 核查，核查情况与意见如下： 一、本次日常关联交易执行及调整情况 公司于 2025 年 4 月 14 日召开第二届董事会第八次会议、第二届监事会第 七次会议以及第二届董事会独立董事专门会议第二次会议分别审议通过了《关 于预计 2025 年度日常关联交易的议案》，同意公司（含子公司）对 2025 年度日 常关联交易额度进行预计，涉及金额合计 446.00 万元，主要用于向相关关联方 购买原材料、向关联方销售商品以及接受关联方提供的技术服务。关联董事肖 志华、张俊杰回避表决，获 ...

国泰海通证券股份有限公司 关于上海奥浦迈生物科技股份有限公司 首次公开发行部分限售股上市流通的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐机构"）作为 上海奥浦迈生物科技股份有限公司（以下简称"奥浦迈"或"公司"）首次公开 发行股票并在科创板上市持续督导的保荐机构，根据《证券发行上市保荐业务管 理办法》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上市 公司自律监管指引第 1 号——规范运作》等法律法规的相关规定，对奥浦迈首次 公开发行部分限售股上市流通事项进行了核查，核查情况及核查意见如下： 一、本次上市流通的限售股类型 经中国证券监督管理委员会（以下简称"中国证监会"）于 2022 年 6 月 13 日出具的《关于同意上海奥浦迈生物科技股份有限公司首次公开发行股票注册的 批复》（证监许可〔2022〕1232 号），同意上海奥浦迈生物科技股份有限公司 （以下简称"奥浦迈"或者"公司"）首次公开发行股票的注册申请，并经上海证券 交易所同意，公司首次向社会公众公开发行人民币普通股 2,049.5082 万股，并于 本为 8,198.0328 万股，其中，有限售条件流通股 6,50 ...

国泰海通证券股份有限公司 关于上海奥浦迈生物科技股份有限公司 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐机构"）作为 上海奥浦迈生物科技股份有限公司（以下简称"奥浦迈"或"公司"）首次公开 发行股票并在科创板上市持续督导的保荐机构，根据《证券发行上市保荐业务管 理办法》《上市公司募集资金监管规则》《上海证券交易所科创板股票上市规则》 《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等有关法 律法规和规范性文件的要求，就奥浦迈使用暂时闲置募集资金（含超募资金）进 行现金管理的事项进行了审慎核查，并发表如下核查意见： 二、募集资金投资项目的基本情况 根据《上海奥浦迈生物科技股份有限公司科创板首次公开发行股票招股说明 书》，公司募集资金投资项目及募集资金使用计划如下： | 序 | 投资总额 | 使用募集资 | | 项目环保批 | | --- | --- | --- | --- | --- | | 项目名称 | | 金投入金额 | 项目备案批文号 | | | 号 | （万元） | | | 文号 | | | | （万元） | | | | 奥浦迈 | | | 项目代码： | 沪自贸临管 | ...

Summary of Key Points Core Viewpoint - The company is increasing the implementation subjects for certain fundraising projects and establishing a dedicated fundraising account to enhance the efficiency of fund usage and project execution, aligning with its overall development strategy [4][5][6]. Fundraising Basic Information - The company was approved to issue 30,707,070 shares at a price of 5.08 RMB per share, raising a total of 1,559,919,156 RMB, with a net amount of 1,418,966,238.97 RMB after deducting issuance costs [1]. Fund Usage Status - As of June 30, 2025, the total investment for the projects is 75,678.02 million RMB, with 75,000.00 million RMB already invested, indicating a significant progress in fund utilization [2]. New Implementation Subject - The company plans to establish a wholly-owned subsidiary, Ningbo Embodied Intelligent Robot Innovation Center Co., Ltd., to serve as the new implementation subject for the project "Industrial Digital Product Technology Upgrade Application and Medical Robot R&D" [3][4]. New Fundraising Account - A new fundraising account will be established to ensure proper management and usage of the funds, with agreements signed between the new subject, the company, and the commercial bank [4][5]. Reasons and Impact of Changes - The changes are driven by the actual needs of the company's business development, aiming to facilitate project execution without altering the investment direction or project content, thus ensuring resource allocation efficiency [4][6]. Review Procedures and Opinions - The board approved the changes without needing a shareholder meeting, and the supervisory board confirmed that the changes comply with relevant regulations and will not adversely affect the company's financial status or shareholder interests [4][5].